Treat to Target in Spondyloarthritis: The Time has Come

ISSN: 1875-6360 (Online)
ISSN: 1573-3971 (Print)

Volume 13, 3 Issues, 2017

Download PDF Flyer

Current Rheumatology Reviews

This journal supports open access

Aims & ScopeAbstracted/Indexed in

Submit Abstracts Online Submit Manuscripts Online

Dr. Serena Guiducci
Department of Biomedicine, Division of Rheumatology
University of Florence

View Full Editorial Board

Subscribe Purchase Articles Order Reprints

Treat to Target in Spondyloarthritis: The Time has Come

Current Rheumatology Reviews, 10(2): 87-93.

Author(s): Yasser El Miedany.

Affiliation: Darent Valley Hospital, Dartford, Kent. UK.


Recent publications have proposed revisions to disease classification criteria, new definitions of early diagnosis and remission, as well as guidelines for implementing treat-to-target strategies for the management of patients with spondyloarthritis. Despite developments leading to this practice-changing approach, the concept of treat to target for spondyloarthritis has not yet been widely accepted or implemented in standard clinical care. By placing greater emphasis on clinical features that manifest early in the disease process, the early and aggressive treatment of the most common forms of spondyloarthritis (namely ankylosing spondylitis and psoriatic arthritis), has been shown to have favorable patient outcomes in reducing synovial inflammation, delaying joint damage, and maintaining functional status. This article discusses the recent concept of Treat to Target in spondyloarthritis and the importance of early diagnosis of both ankylosing spondylitis (AS) and psoriatic arthritis (PsA). It also highlights the main outcome measures for spondyloarthritis patients achieving treatment goals of low levels of disease activity or clinical remission.


Ankylosing spondylitis, disease activity, psoriatic arthritis, remission, treat to target.

Purchase Online Order Reprints Order Eprints Rights and Permissions

Article Details

Volume: 10
Issue Number: 2
First Page: 87
Last Page: 93
Page Count: 7
DOI: 10.2174/1573397110666140301000430
Price: $58
Global Biotechnology Congress 2017Drug Discovery and Therapy World Congress 2017

Related Journals

Related eBooks

Webmaster Contact: Copyright © 2017 Bentham Science